-
JAGX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Jaguar Health (JAGX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 13.27 mm | 13.27 mm | 13.27 mm | 13.27 mm | 13.27 mm | 13.27 mm |
Cash burn (monthly) | 926.67 k | (no burn) | 3.34 mm | 3.19 mm | 2.11 mm | 2.42 mm |
Cash used (since last report) | 4.91 mm | n/a | 17.69 mm | 16.92 mm | 11.20 mm | 12.80 mm |
Cash remaining | 8.36 mm | n/a | -4.42 mm | -3.65 mm | 2.07 mm | 464.34 k |
Runway (months of cash) | 9.0 | n/a | -1.3 | -1.1 | 1.0 | 0.2 |
13F holders | Current |
---|---|
Total holders | 9 |
Opened positions | 2 |
Closed positions | 3 |
Increased positions | 2 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 3.34 bn |
Total shares | 45.05 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Nantucket Investments | 23.63 mm | $3.15 bn |
Streeterville Capital | 11.50 mm | $0.00 |
Oasis Capital | 4.60 mm | $0.00 |
Mailman Joshua | 4.37 mm | $0.00 |
Iliad Research & Trading | 795.74 k | $3.21 mm |
Geode Capital Management | 81.82 k | $110.46 mm |
Vanguard | 59.50 k | $80.33 mm |
Commonwealth Equity Services | 10.85 k | $15.00 k |
BlackRock | 110.00 | $149.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Oct 24 | Siegel Jonathan B. | Stock option Common Stock | Grant | Acquire A | No | No | 1.29 | 26,500 | 34.19 k | 26,500 |
8 Oct 24 | Wolin Jonathan S. | Common Stock | Grant | Acquire A | No | No | 0 | 4,922 | 0.00 | 4,955 |
8 Oct 24 | Wolin Jonathan S. | Stock option Common Stock | Grant | Acquire A | No | No | 1.29 | 39,376 | 50.80 k | 39,376 |
8 Oct 24 | Anula Jayasuriya | Stock option Common Stock | Grant | Acquire A | No | No | 1.29 | 21,000 | 27.09 k | 21,000 |
8 Oct 24 | Conte Lisa A | Common Stock | Grant | Acquire A | No | No | 0 | 16,503 | 0.00 | 16,624 |
8 Oct 24 | Conte Lisa A | Stock option Common Stock | Grant | Acquire A | No | No | 1.29 | 132,020 | 170.31 k | 132,020 |
8 Oct 24 | Lizak Carol R. | Common Stock | Grant | Acquire A | No | No | 0 | 4,280 | 0.00 | 4,297 |
8 Oct 24 | Lizak Carol R. | Stock option Common Stock | Grant | Acquire A | No | No | 1.29 | 34,240 | 44.17 k | 34,240 |